论文信息 - Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis

Lymphomatoid papulosis during upadacitinib treatment for rheumatoid arthritis

142 EJD, vol. 32, n◦ 1, January-February 2022 1. Ruzicka T, Larsen FG, Galewicz D, et al. Oral alitretinoin (9cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, doubleblind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140: 1453-9. 2. Al-Dhubaibi MS, Settin AA. The effectiveness of alitretinoin for the treatment of chronic hand eczema: a meta-analysis. Int J Health Sci (Qassim) 2018; 12: 70-9.

S. Iinuma | A. Noguchi | Kei Hayashi | A. Ishida‐Yamamoto

[1] Stanley B. Cohen,et al. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme , 2019, Annals of the Rheumatic Diseases.

[2] S. Kárpáti,et al. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab. , 2019, Acta dermatovenerologica Croatica : ADC.

[3] Ji-Hye Park,et al. Lymphomatoid Papulosis in a Patient Treated with Adalimumab for Juvenile Rheumatoid Arthritis , 2012, Dermatology.

[4] R. Dummer,et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. , 2011, Blood.

[5] S. Whittaker,et al. Lymphomatoid papulosis in a patient with atopic eczema on long‐term ciclosporin therapy , 2005, The British journal of dermatology.